Search

Emergent BioSolutions, PharmAthene Respond to Anthrax RFP

Emergent BioSolutions, Inc. [EBS], and PharmAthene, Inc. [PIP], have each submitted proposals to the Department of Health and Human Services (HHS) Request for Proposals issued earlier this year for a next-generation anthrax vaccine. Emergent BioSolutions' Recombinant Protective Antigen (rPA) vaccine is a reformulated and more stable form of the rPA 102 vaccine originally developed at the U.S. Army Medical Research Institute of Infectious Diseases. rPA 102 has completed one Phase II clinical trial. PharmAthene's rPA candidate is SparVax, which has…

Subscriber-only content. Please log in below.

Not a subscriber or registered user yet?

Please contact us at clientservices@accessintel.com or call us at 888-707-5814 (Monday – Thursday 9:00 a.m. – 5:30 p.m. and Friday 9:00 a.m. – 3:00 p.m. ET.), to start a free trial, get pricing information, order a reprint, or post an article link on your website.



Congress Updates

House Heads For Recess Without Moving On NDAA After Procedural Vote Fails

The House will leave for the Fourth of July recess without moving forward on its $1.15 trillion fiscal year 2027 National Defense Authorization Act (NDAA), with a procedural vote to […]


Bipartisan Group Of House Members Introduce U.S.-Ukrainian Co-Production Bill For Unmanned Systems

A bipartisan group of six House legislators have introduced the Strategic Unmanned Systems Partnership Act–a bill to improve drone collaboration between the U.S. and Ukraine. Rep. Michael McCaul (R-Texas), the […]


Will $4 Billion For SB-AMTI/Space Data Network Backbone In Supplemental Reduce Or Add To Planned Funding For Systems In Reconciliation?

Nearly all of the Department of the Air Force’s fiscal 2027 procurement and research and development (R&D) budget for space-based air moving target indication (SB-AMTI) and the Space Data Network […]


House Appropriators ‘Concerned’ With JLTV A2 Delays, Shift Funds For Marines’ Second Supplier Effort

House appropriators have said they’re “seriously concerned” with Joint Light Tactical Vehicle (JLTV) A2 delays, as their fiscal year 2027 defense spending bill shifts funds to support the Marine Corps’ […]